CARsgen Therapeutics Announces NDA Acceptance of Satri-cel by China’s NMPA

CARsgen Therapeutics Submits New Drug Application for Satri-cel to China’s NMPA

CARsgen Presents Results of GPRC5D CAR-T CT071 at EHA 2025

CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting

CARsgen’s Satri-cel Granted Priority Review by the NMPA

CARsgen’s Satri-cel Abstract Available on ASCO Website

CARsgen’s CT071 Abstract Published on EHA Website

CARsgen Announces Preliminary Clinical Data for Allogeneic BCMA CAR-T CT0596, Demonstrating Favorable Safety and Efficacy

EHA Preview | CARsgen^® to Present Results of CT071 at 2024 EHA Annual Congress

CARsgen^® Announces Abstract of Satri-cel Research Results Accepted for Oral Presentation at 2025 ASCO Annual Meeting